BAZAAR PULSE
invest4Edu
MARKET SNAPSHOT
Summary | Date | Stock | Author | LTP | Target | Price at reco (Change since reco%) |
Upside(%) | Type | Report | Discuss | |
---|---|---|---|---|---|---|---|---|---|---|---|
24 Jul 2025 | Nifty 50 |
invest4Edu
|
24837.00 | 25219.90 (-1.52%) |
Daily Note
|
||||||
24 Jul 2025 | Nifty 50 |
SBI Securities
|
24837.00 |
Daily Note
|
|||||||
24 Jul 2025 | Bank Nifty |
SBI Securities
|
56528.90 |
Daily Note
|
|||||||
23 Jul 2025 | Indiqube Spaces |
Hem Securities
|
IPO Note
|
INDIQUBE SPACES LIMITED
Hem Securities
Company is a managed workplace solutions company offering comprehensive, sustainable, and technology-driven workplace solutions dedicated to transforming the traditional office experience. Company's diverse solutions range from providing large corporate offices (hubs, i.e., the main office of company's clients wherein key functions, leadership teams, and primary operations are based, and is typically located in a central or strategic area) to small branch offices (spokes, i.e., smaller,...
|
|||||||
23 Jul 2025 | Westlife Foodworld |
Motilal Oswal
|
767.70 | 750.00 | 777.30 (-1.24%) | Target met |
Neutral
|
Similar weak print; strengthening presence in South
Motilal Oswal
Westlife Foodworld (WESTLIFE) reported revenue growth of 7% YoY to INR6.5b in 1QFY26, with same-store sales growth (SSSG) of 0.5% YoY (est. 1.5%) on a favorable base (-6.7% in 1QFY25). Average sales per store rose 1% YoY to INR62m (annually) in 1QFY26.
|
|||
23 Jul 2025 | United Breweries |
Motilal Oswal
|
2033.50 | 2000.00 | 2016.90 (0.82%) | -1.65 |
Neutral
|
Beat in volume growth; pressure on margins
Motilal Oswal
United Breweries (UBBL) delivered strong revenue growth of 16% YoY (est. 10%) in 1QFY26. Volume growth was 11% YoY (est. 4%, 5% in 4Q, 6% in FY25), aided by share gain and a low base from the election-impacted
quarter last year. |
|||
23 Jul 2025 | KEI Industries |
Motilal Oswal
|
3881.80 | 4200.00 | 3970.30 (-2.23%) | 8.20 |
Neutral
|
||||
23 Jul 2025 | Infosys |
Motilal Oswal
|
1515.70 | 1750.00 | 1574.50 (-3.73%) | 15.46 |
Neutral
|
||||
23 Jul 2025 | Dr. Reddy's Labs |
Motilal Oswal
|
1277.90 | 1190.00 | 1247.40 (2.45%) | -6.88 |
Neutral
|
Out-licensing income/lower R&D spend drive better-thanexpected EBITDA
Motilal Oswal
Dr Reddy’s Labs (DRRD) reported sales in line with our estimates in 1QFY26, while EBITDA/PAT came in higher than expected, primarily led by higher outlicensing income and lower R&D expenses.
|
|||
23 Jul 2025 | Persistent Systems |
Motilal Oswal
|
5150.50 | 6800.00 | 5605.50 (-8.12%) | 32.03 |
Buy
|
||||
more
loading
|